20/20 Biolabs, Inc. Common Stock Share Price
NASDAQ: AIDX
Live 20/20 Biolabs, Inc. Common Stock Share Price Chart
O H L
20/20 Biolabs, Inc. Common Stock Performance Overview
Days Range
▼
$0.48Low
$0.48High
Markets Today
| Previous Close | $0.47 |
|---|---|
| Open | $0.48 |
| Volume | 34,253 |
| Day's Range | $0.48 - $0.48 |
| 52W Range | NA |
| Market Cap | $6.14 M |
Historical Performance
| 1M Returns | -6.84 |
|---|---|
| 3M Returns | -26.80 |
| 6M Returns | -75.72 |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
20/20 Biolabs, Inc. Common Stock Fundamentals
| Market Cap | $6.14 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $6.14 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
20/20 Biolabs, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Total Revenue + | $353.38 K | $730.57 K |
| Gross Profit + | $62.88 K | $304.73 K |
| Operating Income | -$1.44 M | -$1.24 M |
| EBITDA | -$1.43 M | -$1.24 M |
| Interest Expense | -$267.01 K | -$272.25 K |
| Depreciation | $17.93 K | $6.68 K |
| Income Before Tax | -$2.17 M | -$1.51 M |
| Income Tax Expense | $0 | $0 |
| Net Income + | -$2.17 M | -$1.51 M |
| Net Profit Margin | -615.45% | -206.19% |
20/20 Biolabs, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Share Capital | $104.43 K | $122.51 K |
| Reserve & Surplus | -$35.42 M | -$36.93 M |
| Non-Current Liabilities | $466.18 K | $412.64 K |
| Current Liabilities | $2.58 M | $2.55 M |
| Total Liabilities | $3.05 M | $2.96 M |
| Fixed Assets | $251.99 K | $239.69 K |
| Current Assets | $4.70 M | $5.08 M |
| Total Assets | $5.80 M | $6.12 M |
20/20 Biolabs, Inc. Common Stock Cash Flow
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Net Income | -$2.17 M | -$1.51 M |
| Operating Cash Flow | -$1.29 M | -$605.46 K |
| Investing Cash Flow | -$5.35 K | -$7.50 K |
| Financing Cash Flow | $4.49 M | $940.00 K |
| Change in Cash | $3.19 M | $327.04 K |
20/20 Biolabs, Inc. Common Stock Return Calculator
The 20/20 Biolabs, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About 20/20 Biolabs, Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
Popular Stocks
FAQs
What is the share price of 20/20 Biolabs, Inc. Common Stock today?
20/20 Biolabs, Inc. Common Stock (AIDX) share price as of September 18, 2026 is $0.47. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of 20/20 Biolabs, Inc. Common Stock?
Yes, Indian Investors can invest in the 20/20 Biolabs, Inc. Common Stock (AIDX) Share by opening an international trading account with Angel One.
How can I purchase 20/20 Biolabs, Inc. Common Stock shares in India?
Purchasing 20/20 Biolabs, Inc. Common Stock (AIDX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying 20/20 Biolabs, Inc. Common Stock (AIDX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of 20/20 Biolabs, Inc. Common Stock?
Yes, you can purchase fractional shares of 20/20 Biolabs, Inc. Common Stock (AIDX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of 20/20 Biolabs, Inc. Common Stock?
The market capitalization of 20/20 Biolabs, Inc. Common Stock on September 18, 2026, is $6.14 M.
In which sector 20/20 Biolabs, Inc. Common Stock belongs?
20/20 Biolabs, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in 20/20 Biolabs, Inc. Common Stock stocks?
In order to invest in 20/20 Biolabs, Inc. Common Stock (AIDX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
